Jason Laine

Medical Marijuana Shift Brings Big Stakes for the Midwest 0
- MEDICAL MARIJUANA
- May 6, 2026
The Trump administration’s decision to reclassify medical marijuana from Schedule I to Schedule III could quietly remake the Midwest cannabis landscape, even as prohibition holds firm in states like Wisconsin. The federal move leaves recreational marijuana untouched but opens the door for medical operators to access tax deductions, federal credits, and mainstream banking services that
READ MORE
Medical Marijuana Reclassified, But CBD Rules Largely Unchanged 0
- CANNABIS OIL
- May 5, 2026
Federal drug policy took a notable shift on April 23, when Acting U.S. Attorney General Todd Blanche ordered state-licensed medical marijuana moved from Schedule I to Schedule III, a category reserved for substances with “moderate to low” dependence risk. The change acknowledges growing public support for medical cannabis but stops short of altering federal rules
READ MORE

Alabama Medical Marijuana Launch Delayed Five Years, Now Set for Early May 0
- MEDICAL MARIJUANA
- April 30, 2026
After nearly five years of legislative approval and extensive litigation, Alabama’s medical cannabis program is finally approaching launch. According to Alabama.com, the first biomass was delivered to processors on April 10, with dispensaries expected to open in early to mid-May. Alabama’s program prohibits smokable forms, restricting products to tablets, tinctures, patches, oils, and peach-flavored gummies. The
READ MORE
DOJ Reclassifies Medical Marijuana in ‘Historic’ Policy Shift 0
- MEDICAL MARIJUANA
- April 28, 2026
The U.S. Department of Justice has ordered looser federal regulation of state-legal medical marijuana, in what advocates are calling a “historic” shift in federal drug policy. Under an order signed by acting Attorney General Todd Blanche, many cannabis products will move from Schedule I, the government’s strictest drug category, to Schedule III, aligning them with
READ MORE